Paul Quinlan - Aug 29, 2024 Form 3 Insider Report for Oruka Therapeutics, Inc. (ORKA)

Role
General Counsel and Secretary
Signature
/s/ Paul Quinlan
Stock symbol
ORKA
Transactions as of
Aug 29, 2024
Transactions value $
$0
Form type
3
Date filed
9/6/2024, 05:03 PM
Previous filing
Mar 22, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ORKA Stock Option (Right to Buy) Aug 29, 2024 Common Stock 229K $6.84 Direct F1
holding ORKA Warrant (Right to Buy) Aug 29, 2024 Common Stock 100K $7.80 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase 228,563 shares of the Issuer's common stock, one quarter of which will vest on April 30, 2025, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date.
F2 This warrant represents a right to purchase 99,996 shares of the Issuer's common stock, one quarter of which will vest on April 30, 2025, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

Remarks:

Exhibit 24 - Power of Attorney